Just raised · Biotech & life sciences · November 2026
Recently funded biotech startups
58 biotech startups raised in the last 90 days, 39 of them in the last 30 days. Median round: $31.2M.
- Companies
- 58in the last 90 days
- Last 7 days
- 12new rounds
- Raised
- $2.8Bdisclosed
- Hiring now
- 643 open roles
Jump to the list · Updated · Download all 58 as CSV · The numbers · How it works · RSS
Latest signals
- Biomatter raised $18M Series A, backed by UVC Partners
- VectorY Therapeutics raised €74.5M
- Nanopath raised $25M Series B, backed by Alumni Ventures and SV Health Investors’ MedTech Convergence Fund
- Oyster Therapeutics raised $60M
- Fathom Therapeutics raised $55M Series A, backed by Sutter Hill Ventures
- SRTD Biotech raised €31.5M Seed
Showing 30 of 58 companies
Nanopath
nanopath.com Nanopath website (opens in a new tab)Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm.
Backed by Alumni Ventures, SV Health Investors’ MedTech Convergence Fund +3
- Hiring with no recruiter role open
- Leadership hire
- Hiring with no recruiter role open
Boltz
boltz.com Boltz website (opens in a new tab)Foundational AI for Biology and Chemistry. Frontier models for designing all of life
Executive Gabriele Corso
- Leadership hire
Biomatter
biomatter.com Biomatter website (opens in a new tab)Engineering proteins for health and sustainable manufacturing.
Backed by UVC Partners
CEO and co-founder Laurynas Karpus
VectorY Therapeutics
Neobe
Oyster Therapeutics
Fathom Therapeutics
fathomtx.com Fathom Therapeutics website (opens in a new tab)The Molecular Frontier
Backed by Sutter Hill Ventures
SRTD Biotech
Delix Therapeutics
LionBio
lion.bio LionBio website (opens in a new tab)LionBio is the nasal peptide company, starting with a nasal GLP-1. We
Rongu Bio
Alethiomics
Setara Biosciences
setarabiosciences.com Setara Biosciences website (opens in a new tab)Setara Biosciences develops small-molecule precision medicines that target the underlying genetic causes of rare diseases, including CMT2C.
Pathos
Nouscom
Kaigene
Executive Minjae Shin
- Job board found, no roles yet
Anaheim Bio
anaheimbio.com Anaheim Bio website (opens in a new tab)Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients
FluoRok
fluorok.com FluoRok website (opens in a new tab)FluoRok makes fluorochemicals without hazardous hydrogen fluoride (HF). Safer chemistry and better economics for batteries, pharmaceuticals and more.
Backed by Orano Ventures Fund/Supernova Invest, Bidra Innovation Ventures
Founder and CEO Gabriele Pupo
Specific Biologics
Backed by Hatteras Venture Partners, Genesys Capital +3
CEO Brent Stead
Thryv
Scimplify
scimplify.com Scimplify website (opens in a new tab)Scimplify specialises in pharmaceutical, life science, agrochemical, metallurgy, and elemental derivatives, right from raw material sourcing and R&D…
Backed by Hitachi Ventures
Estuary Biotherapeutics
Executive Wayne Sackett
Altay Therapeutics
Teal Health
tealhealth.ai Teal Health website (opens in a new tab)Teal Health is on a mission to design a better healthcare experience for women - starting with cervical cancer screenings. The Teal Wand is the first…
- Leadership hire
Chickadee Biomedicines
Executive Weining Lu
No companies match these filters.
The numbers
Biotech startups funded in the last 90 days: 58 companies, $2.8B disclosed. Each company counts once, by its latest round.
Rounds per month
By the month of each company's latest round. August is partial because the list keeps 90 days, and November is still running.
| Month | Companies |
|---|---|
| Aug 2026 | 2 |
| Sep 2026 | 11 |
| Oct 2026 | 27 |
| Nov 2026 | 18 |
By round
By headquarters country
Of the 20 companies whose country we know.
By round size
Median round: $31.2M.
Also tagged as
A company can sit in more than one industry, so shares add up to more than 100%.
Who is hiring
Open roles counted every day on each company's own job board.
- Posting roles now
- 6 companies · 10%
- Open roles in total
- 43
- Median open roles, when hiring
- 6
- Roles by team
- Engineering 59% · Sales and marketing 10% · Other 31%
- Leadership hire
- 3 companies
- Hiring with no recruiter role open
- 2 companies
- Job board found, no roles yet
- 1 companies
Get the Monday list
Every Monday: the startups that raised in the past week, their open roles and a CSV you can load into your CRM. Free.
How recruiters use this list
Sort by recruiter fit, filter to your niche, and save the companies that fit. The pitch email button drafts an opener from the round and their open roles. Reach the founder or head of talent while the headcount plan is still being written.
Recruitment leads, rankedWhere the rounds come from
Funding announcements in the news and trade press, plus every SEC Form D filed by a young US company, the notice it files when it sells shares. Equity rounds only: debt, fund raises and running totals are left out. Every card links to its source.
The funding reportHow this list is built
- Sources. Funding announcements found in news and trade-press feeds every hour, plus every SEC Form D filed by a US company incorporated in the last seven years that sold $1M or more, read from the SEC's daily filing index. Every card links to where the round came from.
- What counts. Equity rounds only. Debt, grants, revenue-based "growth capital", fund raises, crypto and betting are left out. A company appears once, by its latest round; a second report of the same round is merged into the first.
- SEC filings. A Form D shows the amount sold so far and the people running the company, not the round name or the investors, so those cards say "SEC filing". When the round is announced later, the news version replaces it.
- Open roles. We find each company's website and its public job board (Greenhouse, Lever, Ashby, Workable and others) and count the open roles every day, so you can see the change since the raise. Where only a careers page exists, we link it and do not guess a number.
- Recruiter fit (out of 100). Recency of the round up to 30 points, round size up to 20, open roles up to 20, hiring growth since the raise up to 15, plus 10 when they are hiring with no recruiter role open, 5 for a leadership hire and 8 when a job board is live with no roles yet. When we cannot count their roles, the score is capped at 40.
- Industries and countries come from the headline first and the company's own website second. Investors come from the announcement. Spotted a mistake? Tell us and we fix it.
Maintained by Ryan Bradshaw, a recruiter and the editor of Work Insiders. Tracking started August 17, 2026; older rounds from SEC filings are added in the background.
Common questions
How many biotech startups raised funding recently?
58 biotech startups announced a round or filed an SEC Form D in the 90 days to 12 Nov 2026, and 39 in the last 30 days. Each company counts once, by its latest round.
Which biotech startups raised most recently?
The latest include Biomatter ($18M Series A), VectorY Therapeutics (€74.5M), Nanopath ($25M Series B), Chickadee Biomedicines ($1M), Neobe (€6.1M). The list on this page can be sorted by newest, round size, open roles or recruiter fit.
How much do biotech startups raise?
The median round is about $31.2M across the 58 rounds with a disclosed amount. The most common size is $25–50M (16 rounds).
How many of these biotech startups are hiring?
6 of them (10%) have open roles on a public job board right now, 43 roles in total. We count each company's own job board every day, so you can see who is hiring fastest since the raise.
How often is this list updated?
Every hour for news and SEC filings, and every day for open roles. Last refreshed 12 Nov 2026, 11:46 am ET.
Can I download the full list?
Yes, free. Use Download CSV above the list for the rounds that match your filters, or the CSV link at the top for every company on this page with investors, people, open roles and job titles. No sign-up needed.
